Home Press Releases

Press Releases

Filters
September 17, 2014

Debiopharm Diagnostics portfolio company Biocartis ships its first Idylla instrument

Read more
September 4, 2014

Debiopharm Group™’s innovative antibiotic Debio 1450 – developed from its proprietary plateform Fabiotics – Receives Qualified Infectious Disease Product (QIDP)…

Read more
June 26, 2014

Debiopharm Group™ and Nobelex Biotech start two collaborations on development of new antibiotics against N. gonorrhoeae and enteric species

Read more
June 24, 2014

Debiopharm Group™ and TCG Lifesciences Ltd. announce successful completion of first phase of research collaboration on discovery of novel antibiotics

Read more
June 19, 2014

Debiopharm Group™ Announces Initiation of a Phase I Study of Debio 1450, an IV/oral Potent Antibiotic Active Against Staphylococcal Infections

Read more
May 28, 2014

Debiopharm Group™ moves forward three of its oncology clinical programs and will present the recent progresses at the 50th American…

Read more
May 27, 2014

Orient EuroPharma and Debiopharm Group™ announce their partnership and the launch of Pamorelin LA in Singapore

Read more
April 24, 2014

Evotec and Debiopharm Group™ to collaborate on development of new treatment for cancer

Read more
April 8, 2014

Curis and Debiopharm Group™ Report Preclinical Data for Debio 0932 at AACR Annual Meeting 2014

Read more